Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This was a long-term safety study HPN-100 in urea cycle disorder (UCD) subjects. Subjects
were assessed regularly for safety and control of their venous ammonia. Hyperammonemic events
were characterized with respect to contributing factors, such as intercurrent illness, diet,
and noncompliance with medication.